Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 27,290 | 25,883 | 24,373 | 23,407 | 29,780 |
| Cost of Goods | 28,327 | 23,612 | 22,415 | 21,342 | 28,052 |
| Gross Profit | -1,037 | 2,272 | 1,958 | 2,065 | 1,727 |
| Operating Expenses | 232 | 740 | 810 | 826 | 924 |
| Operating Income | -1,269 | 1,532 | 1,148 | 1,239 | 803 |
| Other Income | 574 | -150 | -405 | -69 | 1,454 |
| Pre-tax Income | -695 | 1,381 | 743 | 1,170 | 2,257 |
| Income Tax | -5 | 486 | 270 | 413 | 83 |
| Net Income Continuous | -689 | 895 | 473 | 757 | 2,174 |
| Net Income | $195 | $895 | $473 | $757 | $1,690 |
| EPS Basic Total Ops | 0.01 | 0.17 | -0.04 | 0.07 | 0.16 |
| EPS Basic Continuous Ops | -0.07 | 0.17 | -0.04 | 0.07 | 0.20 |
| EPS Basic Discontinuous Ops | 0.08 | 0.00 | 0.00 | 0.00 | -0.04 |
| EPS Diluted Total Ops | 0.01 | 0.17 | -0.04 | 0.07 | 0.13 |
| EPS Diluted Continuous Ops | -0.07 | 0.17 | -0.04 | 0.07 | 0.17 |
| EPS Diluted Discontinuous Ops | 0.07 | 0.00 | 0.00 | 0.00 | -0.04 |
| EBITDA(a) | $-1,037 | $2,272 | $1,958 | $2,065 | $1,727 |